Characterization of the Potent and Highly Selective A2A Receptor Antagonists Preladenant and SCH 412348 [7-[2-[4-2,4-Difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in Rodent Models of Movement Disorders and Depression
Robert A. Hodgson(Merck & Co., Inc., Rahway, NJ, USA (United States)), John C. Hunter, Rosalia Bertorelli(San Raffaele University of Rome), Jean E. Lachowicz, Geoffrey B. Varty(Institute of Neurobiology), Eric M. Parker(University of New Hampshire), Elisa Nicolussi(San Raffaele University of Rome), Andrew W. Stamford(Merck & Co., Inc., Rahway, NJ, USA (United States)), Mary Cohen-Williams, A Forlani(San Raffaele University of Rome), B Neustadt, Silva Fredduzzi(San Raffaele University of Rome), Francesco Impagnatiello(Tethys Research Institute), Leonard E. Parra, Ying Zhai, Angelo Reggiani(San Raffaele University of Rome), Carolyn Foster, Guy A. Higgins
Cited by 149
Related Papers
Chronic Treatment with the γ-Secretase Inhibitor LY-411,575 Inhibits β-Amyloid Peptide Production and Alters Lymphopoiesis and Intestinal Cell Differentiation
|Journal of Biological Chemistry|2004|716
Protein misfolding in neurodegenerative diseases: implications and strategies
|Translational Neurodegeneration|2017|671
The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients
|Science Translational Medicine|2016|416
MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition
|Journal of Pharmacology and Experimental Therapeutics|2015|336
Reconstitutively active G protein-coupled receptors purified from baculovirus-infected insect cells.
|Journal of Biological Chemistry|1991|283